First Trust Advisors LP Sc Pharmaceuticals Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.93 - $7.15 $116,417 - $168,840	-23,614 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.19 - $7.38 $4,271 - $6,073	-823 Reduced 3.37%	23,614 $144,000
Q1 2021 May 14, 2021	BUY	$5.65 - $7.66 $11,090 - $15,036	1,963 Added 8.73%	24,437 $163,000
Q4 2020 Feb 02, 2021	SELL	$5.17 - $9.41 $5,247 - $9,551	-1,015 Reduced 4.32%	22,474 $119,000
Q3 2020 Nov 05, 2020	BUY	$7.12 - $8.86 $167,241 - $208,112	23,489 New	23,489 $175,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $97M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.